Kyverna Therapeutics (KYTX) Payables (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Payables of $11.6 million for Q1 2026, up 118.68% on a QoQ basis from $5.3 million in Q4 2025, and up 36.96% year-over-year from $8.5 million in Q1 2025.
Kyverna Therapeutics (KYTX) Payables (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Payables history runs 4 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- Quarterly Payables rose 36.96% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (up 36.96% YoY) and the FY2025 annual result came in at $5.3 million, up 14.75% from the prior year.
- Payables was $11.6 million for Q1 2026 at Kyverna Therapeutics, up from $5.3 million in the prior quarter.
- Across five years, Payables topped out at $11.6 million in Q1 2026 and bottomed at $3.0 million in Q3 2025.
- A 4-year average of $7.0 million and a median of $6.4 million in 2024 frame the typical range for Payables.
- Peak annual rise in Payables reached 104.01% in 2025, while the deepest fall reached 69.63% in 2025.
- Kyverna Therapeutics' Payables stood at $4.4 million in 2023, then grew by 6.1% to $4.6 million in 2024, then grew by 14.75% to $5.3 million in 2025, then surged by 118.68% to $11.6 million in 2026.
- Business Quant data shows KYTX's Payables at $11.6 million in Q1 2026, $5.3 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - | 11.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | 9.92 Mn |
| Mar 31, 2025 | 8.47 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 9.93 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 4.36 Mn |